COVID-19 treatment

A box of Evusheld, an antibody therapy developed by pharmaceutical company AstraZeneca for the prevention of COVID-19 in immunocompromised patients, is seen in February at the AstraZeneca facility for biological medicines in Sweden

Health & Safety

Officials boost access to a drug that can protect the immunocompromised from COVID-19

6:20pm July 28, 2022

by Rob Stein

Evusheld, a course of injected antibodies, helps protect people with weak immune systems for up to six months. The government is making it available through pharmacies and individual providers.

Health & Safety

Omicron is driving test and treatment shortages — what this means for the Triad

6:00am January 12, 2022

by April Laissle

The omicron variant of COVID-19 has driven a massive surge in case numbers that has Triad health care providers desperate for relief.

Merck says it will have 10 million packs of its new COVID-19 treatment available by the end of the month.

The FDA has authorized Merck's COVID pill for home use — the 2nd in 2 days

2:42pm December 23, 2021

The medicine, called molnupiravir, is taken twice a day for five days and works by preventing the virus from replicating. Merck says it will have 10 million packs available by the end of the month.

A COVID-19 antiviral pill called molnupiravir from Merck and Ridgeback Biotherapeutics is being considered by the Food and Drug Administration for emergency use in the coronavirus pandemic.

Health & Safety

An FDA panel supports Merck COVID drug in mixed vote

6:18pm November 30, 2021

by Scott Hensley

If the Food and Drug Administration authorizes use of the drug, called molnupiravir, it would be the first oral COVID-19 treatment that could be taken at home.

Health & Safety

Tested Positive For COVID-19? Here's What You Need To Know About Monoclonal Antibody Treatments

11:12am September 03, 2021

by April Laissle

As the delta variant continues to drive record case numbers and hospitalizations, monoclonal antibody treatments for the virus are becoming increasingly popular.

Queue Listen Now

Jennifer Minhas had been a nurse for years when she contracted COVID-19 in 2020. Since then, lingering symptoms — what's known as long-haul COVID-19 — made it impossible for her to work. For months, she and her doctors struggled to understand what was

Health & Safety

After Months Of A Racing Heart And Burning Feet, A COVID Long-Hauler Gets A Diagnosis

7:01am May 22, 2021

by Allison Aubrey

Jennifer Minhas is among those who suffer lingering problems after COVID-19. A diagnosis of POTS, a little-known circulation disorder that mostly affects women, offers a way forward.

Health & Safety

Antibody Drugs For COVID-19 Are A Cumbersome Tool Against Surges

10:56am April 16, 2021

by Richard Harris

Drugs that can help keep COVID-19 patients out of the hospital are playing only a small role in Michigan, where the pandemic is accelerating. Logistical challenges are to blame.

Queue Listen Now

A nurse tends to a Covid-19 patient in the intensive care unit at Providence St. Mary Medical Center in Apple Valley, Calif., on Jan. 11.

Health & Safety

After A Year Battling COVID-19, Drug Treatments Get A Mixed Report Card

7:05am January 22, 2021

by Richard Harris

Drugs for COVID-19 are sorted into three basic categories: They work, they don't work, or there simply isn't enough information to know. A generic steroid is one medicine that proved helpful.

Queue Listen Now

Nurse Salina Padilla prepares an infusion of a COVID-19 antibody treatment at Desert Valley Hospital in Victorville, Calif., in December.

Health & Safety

Tracking Down Antibody Treatment Is A Challenge For COVID-19 Patients

6:43pm January 11, 2021

by Richard Harris

Antibody-based drugs that bind to the coronavirus to prevent it from invading cells can help patients with mild to moderate COVID-19. But the medicines can be tough to find in time.

Queue Listen Now

President Trump boards Marine One for a trip from the White House to Walter Reed National Military Medical Center for COVID-19 treatment in early October. Trump received Regeneron's antibody cocktail during his illness.

Health & Safety

Low Demand For Antibody Drugs Against COVID-19

11:01am December 22, 2020

by Richard Harris

Monoclonal antibodies to prevent severe COVID-19 aren't being used as widely as expected. Medical staff shortages and patient transportation problems are two of the reasons.

Queue Listen Now